A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of 6-month administration of CP-945,598 on:
- weight loss and waist circumference,
- blood pressure, cholesterol, glucose
- other biochemical variables like insulin, leptin, ghrelin, adiponectin, PAI 1, TNF-α
and hsCRP
- the relationship between the concentration of the drug on the blood and the above
parameters
- physical and psychosocial functioning, weight related symptoms, treatment satisfaction,
appetite/hunger/satiety/craving and mood, anxiety, anhedonia and depression